AusPAR: Eptinezumab

Australian Public Assessment Report

AusPAR

AusPAR: Eptinezumab [PDF, 767.02 KB]

AusPAR: Eptinezumab [Word, 644.78 KB]

Attachment: Product information for Eptinezumab [PDF, 383.85 KB]

Attachment: Product information for Eptinezumab [Word, 250.36 KB]

Device/Product Name

Vyepti

Active ingredients

Eptinezumab

AusPAR Date

25 February 2022

Published

3 March 2022

Submission Number

PM-2020-01823-1-1

Submission Type

New biological entity

Decision

Approved